Daiichi Sankyo
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.eu.
Daiichi Sankyo Europe GmbH
Zielstattstr. 48
81379 Munich
Tel: +49 89 78080
Email: [email protected]
URL: www.daiichi-sankyo.eu
MSD
At MSD, known as Merck & Co., Inc. in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
For more information, visit www.msd.de and connect with us on LinkedIn and YouTube.
MSD Sharp & Dohme GmbH
Levelingstraße 4a, 81673
Müchen, Germany
Tel: 0800 673 673 673
Email: [email protected]
URL: https://www.msd.de
Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. We have a 40-year track record in transplant health. Now, through our portfolio and pipeline, we can transform transplant care with the development of medicines which can preserve organ function and improve quality- of-life for transplant recipients.
To know more about us, visit sanofi.com and follow us on Linkedin, X, Instagram, Facebook, TikTok and YouTube
Sanofi
Lützowstr.107, 10785
Berlin, Germany
URL : www.sanofi.com
Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. We focus on core therapeutic areas with high unmet patient needs and technology platforms that enable cutting-edge innovative therapies. Our medicines reach more than 250 million people worldwide.
Reimagine medicine with us: Visit us at https://www.novartis.de/ and https://www.novartis.com/ and connect with us on LinkedIn.
Novartis Pharma GmbH
Roonstraße 25
90429 Nürnberg
Tel: 0911-273-0
URL: https://www.novartis.de
Pierre Fabre
Pierre Fabre Laboratories is a leading French company in the field of medicine and Beauty care with four decades of experience in innovation, development, manufacture and Marketing of oncologics. In 2022, the company devoted around 80% of its R&D spending to Oncology, with a focus on targeted therapies. Founded in 1962 in the south-west of France, the company manufactures 90% of its products in France and employs around 10,000 people worldwide. 86% of the company is owned by the Pierre Fabre Foundation, a government-approved non-profit foundation, and by its own employees under an international employee participation program.
Pierre Fabre Pharma GmbH
Neuer Messplatz 5, 79108 Freiburg
Tel: +49 (0)761 45261-0
Email: [email protected]
URL: www.pierre-fabre.com
Astellas
Astellas is a pharmaceutical company committed to turning innovative science into value for patients. Changing tomorrow is the ethos thaat guides everything we do.
Working at the forefront of healthcare change, Astellas invests in new medicines, technologies and therapeutic areas, and builds partnerships and networks with others who share our vision to improve the future of medicine.
Astellas Pharma GmbH
Ridlerstr. 57, 80339
München/Munich-Germany
URL: http://www.astellas.com/eu
DKMS
DKMS is one of the most significant nonprofit organization in the world dedicated to fighting blood cancer and blood disorders. With twelve entities, a global presence in seven countries on five continents, DKMS strives to save the lives of patients in need of a stem cell transplant. To achieve this, the organization works tirelessly to expand its pool of over 12 million donors, enhance the access to transplantation with its international support programs, improve patient outcome and advance therapies through its Clinical Trials Unit and DKMS Life Science Lab. With its DKMS Collection Centers the organization increases collection capacities.
DKMS Group gGmbH
Tübingen, Germany
URL: https://www.dkms.de/
Incyte
Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
Since 2002, Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders. The Company is advancing a diversified portfolio of clinical candidates across Oncology and Inflammation & Autoimmunity.
Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
For more information, visit Incyte.com and follow @Incyte.
Incyte Biosciences International Sàrl
Rue Docteur-Yersin 12
1110 Morges – Switzerland
Tel: +41 21 581 54 00
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing and commercializing life-changing medicines that transform the lives of patients with serious diseases – often with limited or no options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. Our focus is on neuroscience and oncology, including hematologic and solid tumors. We actively explore new options for patients including novel compounds, small molecule advancements, biologics, and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in more than 90 countries.
Jazz Pharmaceuticals Germany GmbH
Grillparzerstraße 18
81675 München
Tel: +49 (0)89 411 096 60
Tel: +49 (0)89 411 096 61
URL: jazzpharmaceuticals.com
Kyverna
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
Our lead chimeric antigen receptor (CAR) T-cell therapy candidate, KYV-101 is advancing through clinical development with sponsored clinical trials across two broad areas of autoimmune disease: rheumatology and neurology.
Kyverna’s pipeline includes next-generation CAR T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.
Kyverna Therapeutics
Mobile: (818) 219-5170
kyvernatx.com
Medac
At medac group, we believe that health is humanity’s most valuable resource. Since 1970, our mission has been to improve patients’ quality of life worldwide by making the best medical treatments available. As a globally operating pharmaceutical company headquartered in Germany, we provide high-quality medical treatments for patients worldwide in 91 countries. With more than 2.000 employees we are committed to improving human health.
All our products are manufactured in Germany and other European countries to the highest standards, utilizing our own logistics center and production sites, and subsequently distributed worldwide.
We are constantly working to improve authorized medicines and to develop innovative therapies in the fields of rheumatology, urology, hematology, and oncology. Part of our mission is to provide safe, high-quality and innovative original products, as well as generics and biosimilars. In this way, we make vital treatments accessible to those affected.
medac GmbH
Theaterstraße 6 22880
Wedel, Germany
URL: medac-group.com
Neovii
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders.
Visit our booth and see our areas of interest, products and our research and development process.
Neovii’s global headquarter:
Neovii Pharmaceuticals AG
Schlüsselstrasse 12
8645 Rapperswil-Jona
Switzerland
Tel: +41 55 210 05 00
General email: [email protected]
Medical email: [email protected]
Biologics manufacturing site and German operations:
Neovii Biotech GmbH
Am Haag 6-7
82166 Gräfelfing/Germany
Tel: +49 89 898888 0
Email: [email protected]
Ontime Courier
For over 20 years, we have been training stem cell couriers for the voluntary undertaking of worldwide stem cell transports and organizing accompanied transports for leukemia patients in the context of stem cell donation. With almost 50,000 successfully completed transplant deliveries worldwide, an experienced team with the necessary organizational expertise is available to the organizations involved in stem cell donation. In connection with the life-saving mission of stem cell donation, the team is available 24/7/365 for planning, organization, and emergencies during the journey, both for the stem cell courier and the affected stem cell organizations.
We offer services from and to every location on the globe, mainly delivering on the day of donation. Our goal is to create the best and fastest connection for each individual transport in order to contribute to the recovery of affected patients around the world.
Our experience on all 6 continents serving more than 400 transplant centers guarantees the quality you are looking for.
24/7/365 – multi lingual staff – online tracking – we cover all your needs.
[email protected] or +49-89-357373-20 – contact us to find out more!
Prompt response of our well-trained team concerning your request enables quick decisions on your part.
Ontime Courier GmbH
Tel: +49 89 35 73 73 20
Email: [email protected]
URL: www.ontimecourier.com
Takeda
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 240 years of distinguished history in Japan. We have presence in approximately 80 countries, with leading positions in Japan and the U.S., respectively the third and first largest pharmaceutical markets in the world. We will deliver highly innovative medicines and transformative care people globally. That is why we have been commited to post-transplant patients since 2022.
Takeda Pharma Vertrieb GmbH & Co. KG
Potsdamer Str. 125
10783 Berlin, Deutschland
Tel.: 0800 2953333
Email: [email protected]
URL: https://www.takeda.com/de-de
Mallinckrodt (MNK) Therakos
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Therakos is a specialty brand of Mallinckrodt that focuses on the delivery of ECP Immunomodulation. The THERAKOSTM CELLEX™ Photopheresis System is the world’s only fully integrated and validated ECP system and is used by over 300 treatment centres in over 30 countries worldwide.
Beyond the THERAKOS™ CELLEX™ Photopheresis System, we offer a comprehensive range of support services to help enable healthcare professionals (HCPs) to deliver optimised ECP immunomodulation to patients. Therakos have been crafting ECP solutions (products, services and education) since 1987.
To learn more about this product visit www.therakos.eu
Mallinckrodt Pharmaceuticals (Therakos)
3 Lotus Park, The Causeway, Staines-upon-Thames
Surrey, TW18 3AG, UK
Tel: +44 (0) 1784 636 700
Email: [email protected]
URL: www.mallinckrodt.com/ www.therakos.eu
LinkedIn: https://www.linkedin.com/showcase/therakos-institute
Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.
Vertex Pharmaceuticals (Germany) GmbH
Sonnenstr. 19 / Eingang 2, 2. Stock
80331, Munich, Germany
Tel.: +49 89 20602 9900
URL: www.vrtx.de
